The system saw total operating revenues of $873 million in the quarter ended June 30, up from $797.1 million over the same period in 2023, according to its Aug. 28 financial report. Patient service revenue increased 7.8% year over year. Discharges increased 4.6%, resulting in $35.4 million in additional patient service revenue, while changes in payer mix and rates resulted in a net increase of $16.5 million.
Total operating expenses hit $861.5 million in the quarter, up from $788.3 million over the same period last year. The increased costs were attributed to a 6.3% rise in compensation and benefits, a 14.6% increase in supplies and other expenses and a 22.1% increase in license fees.
Net income in the second quarter was $13.3 million, down from $14.1 million over the same period in 2023.
Through the first three quarters of 2024, Lifespan reported an operating income of $71.5 million, up from $1.7 million posted over the same nine-month period in 2023. Its net income through the first three quarters is $134 million, up from $44.6 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
